News

The capital dresses up for science

The European Association of Economy and Competitiveness celebrates the second edition of the Isaac Peral National Award for Research, Science and Innovation The investigation was …

Read more →

Artificial intelligence: key to optimizing clinical decisions in cancer patients

“The OPS (Oncology Precision System) starts from the genetic characteristics of each patient and is capable of proposing the best combination of treatments currently available …

Read more →

KeyZell boosts its cancer treatments

Receive an award for an Artificial Intelligence development.  KeyZell promotes its cancer treatments and for this it has received an award in the II Edition …

Read more →

KeyZell Awarded for Treating Cancer with Biotechnology, Artificial Intelligence

06.28.2022 2:48 pm Biotechnological startup Keisel has been honored at the second edition of the Isaac Perel National Research, Science and Innovation Awards organized by …

Read more →

KeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool

The Spanish biotechnology startup KeyZell, in alliance with the technology company Iakan, has presented an Artificial Intelligence solution capable of recommending personalized treatments for lung …

Read more →

KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn

MADRID, March 17, 2022 /CNW/ — KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing …

Read more →

Starving glioblastoma, the deadliest brain cancer

Glioblastoma is one of the most common, deadly and difficult to treat brain tumors in adults, only 25% of patients survive more than one year. …

Read more →

Precision medicine against cancer: create the most appropriate treatments for each patient with AI

KeyZell develops novel oncology drugs and finds the most efficient combination of treatments according to each genetics and clinical history. Covid-19 placed the importance of …

Read more →

Keyzell and Lãberit join forces to develop artificial intelligence to personalize cancer treatments

Madrid, February 18, 2022. KeyZell, a Spanish biotechnology company focused on the discovery and development of a new generation of anticancer drugs, as well as …

Read more →